Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M69,801Revenue $M6,494Net Margin (%)22.3Z-Score7.0
Enterprise Value $M69,785EPS $1.7Operating Margin %27.9F-Score6
P/E(ttm))55.6Cash Flow Per Share $4.4Pre-tax Margin (%)25.7Higher ROA y-yN
Price/Book15.610-y EBITDA Growth Rate %0Quick Ratio2.7Cash flow > EarningsY
Price/Sales11.05-y EBITDA Growth Rate %22.2Current Ratio2.9Lower Leverage y-yN
Price/Cash Flow17.9y-y EBITDA Growth Rate %1.7ROA % (ttm)10.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)25.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M801ROI % (ttm)17.8Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CELGRay Dalio 2014-03-31 Add0.07%$69.65 - $85.97
($79.51)
$ 87.1610%Add 962.69%142,400
CELGJohn Burbank 2014-03-31 Buy 0.01%$69.65 - $85.97
($79.51)
$ 87.1610%New holding, 1670 sh.3,340
CELGJohn Keeley 2014-03-31 Sold Out $69.65 - $85.97
($79.51)
$ 87.1610%Sold Out0
CELGRonald Muhlenkamp 2013-12-31 Add0.12%$72.25 - $85.39
($79.05)
$ 87.1610%Add 2.87%294,850
CELGRay Dalio 2013-12-31 Buy 0.01%$72.25 - $85.39
($79.05)
$ 87.1610%New holding, 6700 sh.13,400
CELGJohn Keeley 2013-09-30 Buy $60.13 - $77.31
($70.14)
$ 87.1624%New holding, 1320 sh.2,640
CELGMario Gabelli 2013-09-30 Add$60.13 - $77.31
($70.14)
$ 87.1624%Add 29.5%20,940
CELGJohn Hussman 2013-09-30 Sold Out -0.31%$60.13 - $77.31
($70.14)
$ 87.1624%Sold Out0
CELGRonald Muhlenkamp 2013-06-30 Reduce-0.96%$56.1 - $65.09
($60.18)
$ 87.1645%Reduce -21.92%285,770
CELGJoel Greenblatt 2013-06-30 Sold Out -0.01%$56.1 - $65.09
($60.18)
$ 87.1645%Sold Out0
CELGJohn Hussman 2013-03-31 Reduce-0.71%$39.24 - $57.96
($50.79)
$ 87.1672%Reduce -85.25%118,000
CELGJoel Greenblatt 2013-03-31 Reduce-0.17%$39.24 - $57.96
($50.79)
$ 87.1672%Reduce -94.2%4,660
CELGRay Dalio 2013-03-31 Sold Out -0.07%$39.24 - $57.96
($50.79)
$ 87.1672%Sold Out0
CELGJoel Greenblatt 2012-12-31 Add0.16%$35.65 - $41.04
($38.7)
$ 87.16125%Add 989.15%80,314
CELGMario Gabelli 2012-12-31 Add$35.65 - $41.04
($38.7)
$ 87.16125%Add 68.37%17,510
CELGRay Dalio 2012-12-31 Reduce-0.09%$35.65 - $41.04
($38.7)
$ 87.16125%Reduce -52.42%169,762
CELGRonald Muhlenkamp 2012-09-30 Buy 3%$31.48 - $38.64
($35.11)
$ 87.16148%New holding, 183415 sh.366,830
CELGJohn Hussman 2012-09-30 Buy 0.92%$31.48 - $38.64
($35.11)
$ 87.16148%New holding, 500000 sh.1,000,000
CELGRay Dalio 2012-09-30 Add0.03%$31.48 - $38.64
($35.11)
$ 87.16148%Add 23.04%356,762
CELGJoel Greenblatt 2012-09-30 Reduce-0.09%$31.48 - $38.64
($35.11)
$ 87.16148%Reduce -83.94%7,374
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CELG is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CELG John Burbank 2014-03-313,34000.01New Buy
CELG Ray Dalio 2014-03-31142,4000.020.08+962.69%
CELG Ronald Muhlenkamp 2014-03-31298,6500.043.7+1.29%
CELG Mario Gabelli 2014-03-3121,54000.01-3.58%
CELG John Keeley 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Celgene International Inc10% Owner 2014-07-08Buy200,000$10761.9view
KAPLAN GILLADirector 2014-06-09Sell30,000$80.816.66view
CELGENE CORP /DE/10% Owner 2014-05-05Buy1,100,000$42.86101.1view
KARSEN PERRY Asee remarks 2014-05-01Sell23,844$73.3917.44view
Celgene European Investment Co10% Owner 2014-04-29Buy294,800$4495.89view
CELGENE CORP /DE/10% Owner 2014-04-14Buy714,286$71131.29view
CASEY MICHAEL DDirector 2014-03-04Sell25,540$81.176.18view
KARSEN PERRY Asee remarks 2014-03-03Sell4,816$79.538.37view
CASEY MICHAEL DDirector 2014-02-28Sell4,460$82.144.93view
Celgene European Investment Co10% Owner 2014-02-10Buy340,000$29.25194.67view

Press Releases about CELG :

Quarterly/Annual Reports about CELG:

News about CELG:

Articles On GuruFocus.com
Ken Fisher's Top Increases of the First Quarter Apr 22 2014 
David Winters' 2013 Letter to Wintergreen Fund Shareholders Mar 05 2014 
You Can No Longer Ignore Biotech Feb 07 2014 
Trying to Beat the Market Is a Fool’s Errand Oct 17 2013 
Insiders Are Buying Idera Pharmaceuticals Sep 19 2013 
comment on CELG Mar 20 2013 
Growth Stocks: There Is a Lot of Value in this Market Part 2 Sep 27 2012 
High frowth cheap in Jun 30 2012 
52-Week High Companies: CVS, TSM, PM, ROST, CELG Feb 27 2012 
52-Week High Companies: CELG, MON, ECL, SBUX, NWSA Jan 16 2012 


More From Other Websites
[video] No Huddle Offense: Damaged stocks Jul 24 2014
Celgene, Alexion Beat Estimates, But Biotechs Fall Jul 24 2014
S&P 500 ekes out another record close: stock market live blog recap Jul 24 2014
Celgene's (CELG) CEO, Robert Hugin on Q2 2014 Results - Earnings Call Transcript Jul 24 2014
Celgene profit rises but revised outlook disappoints Jul 24 2014
Biotechs beat estimates, but the Street wants more Jul 24 2014
Video: Celgene, Alexion Earnings Top, But Stocks Fall Jul 24 2014
Why Gilead Is A Better Buy Than This Rival Jul 24 2014
Jim Cramer's Stop Trading: Consider Buying Celgene on Friday Jul 24 2014
Celgene Reports Second Quarter 2014 Operating and Financial Results Jul 24 2014
Celgene (CELG) Stock Falls After Mixed Second-Quarter Earnings Jul 24 2014
Celgene profit rises 25 pct up on higher cancer drug sales Jul 24 2014
CELGENE CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 24 2014
7:35 am Celgene beats by $0.01, beats on revs; issues mixed FY14 EPS guidance, guides FY14 revs... Jul 24 2014
Celgene Reports Second Quarter 2014 Operating and Financial Results Jul 24 2014
Q2 2014 Celgene Corp. Earnings Release - Before Market Open Jul 24 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide